CERUS CORP APIC, Share-based Payment Arrangement, Increase for Cost Recognition
CERUS CORP (CERS) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $5.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-30
- CERUS CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $5.50M, a 3.26% decline year-over-year.
- CERUS CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $4.90M, a 26.09% decline year-over-year.
- CERUS CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $5.62M, a 3.53% decline year-over-year.
- CERUS CORP apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $5.68M, a 0.05% increase year-over-year.
- CERUS CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $22.87M, a 0.00% change from fiscal 2024.
- CERUS CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $22.87M, a 12.81% increase from fiscal 2023.
- CERUS CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $20.27M, a 17.11% decline from fiscal 2022.
- CERUS CORP apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $24.46M, a 3.75% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.50M 10-Q · filed 2026-07-30 | $10.40M derived: sum of 2 quarters · filed 2026-07-30 | ||
| 2026-03-31 | $4.90M 10-Q · filed 2026-07-30 | |||
| 2025-12-31 | $22.87M 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $5.62M 10-Q · filed 2025-11-06 | $11.30M derived: sum of 2 quarters · filed 2026-07-30 | $17.94M derived: sum of 3 quarters · filed 2026-07-30 | |
| 2025-06-30 | $5.68M 10-Q · filed 2026-07-30 | $12.32M derived: sum of 2 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $6.63M 10-Q · filed 2026-07-30 | |||
| 2024-12-31 | $22.87M 10-K · filed 2026-03-02 | |||
| 2024-09-30 | $5.83M 10-Q · filed 2025-11-06 | $11.51M derived: sum of 2 quarters · filed 2025-11-06 | $17.36M derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $5.68M 10-Q · filed 2025-11-06 | $11.53M derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | $5.86M 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $20.27M 10-K · filed 2026-03-02 | |||
| 2023-09-30 | $3.98M 10-Q · filed 2024-10-31 | $9.70M derived: sum of 2 quarters · filed 2024-10-31 | $15.37M derived: sum of 3 quarters · filed 2024-10-31 | |
| 2023-06-30 | $5.72M 10-Q · filed 2024-10-31 | $11.39M derived: sum of 2 quarters · filed 2024-10-31 | ||
| 2023-03-31 | $5.67M 10-Q · filed 2024-10-31 | |||
| 2022-12-31 | $24.46M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $5.77M 10-Q · filed 2023-11-02 | $10.78M derived: sum of 2 quarters · filed 2023-11-02 | $17.20M derived: sum of 3 quarters · filed 2023-11-02 | |
| 2022-06-30 | $5.01M 10-Q · filed 2023-11-02 | $11.43M derived: sum of 2 quarters · filed 2023-11-02 | ||
| 2022-03-31 | $6.43M 10-Q · filed 2023-11-02 | |||
| 2021-12-31 | $23.57M 10-K · filed 2024-03-05 | |||
| 2021-09-30 | $5.89M 10-Q · filed 2022-11-03 | $11.70M derived: sum of 2 quarters · filed 2022-11-03 | $17.03M derived: sum of 3 quarters · filed 2022-11-03 | |
| 2021-06-30 | $5.81M 10-Q · filed 2022-11-03 | $11.14M derived: sum of 2 quarters · filed 2022-11-03 | ||
| 2021-03-31 | $5.33M 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $18.03M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $4.85M 10-Q · filed 2021-11-02 | $9.55M derived: sum of 2 quarters · filed 2021-11-02 | $13.31M derived: sum of 3 quarters · filed 2021-11-02 | |
| 2020-06-30 | $4.71M 10-Q · filed 2021-11-02 | $8.46M derived: sum of 2 quarters · filed 2021-11-02 | ||
| 2020-03-31 | $3.75M 10-Q · filed 2021-11-02 | |||
| 2019-12-31 | $13.31M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $3.60M 10-Q · filed 2020-10-29 | $6.73M derived: sum of 2 quarters · filed 2020-10-29 | $9.61M derived: sum of 3 quarters · filed 2020-10-29 | |
| 2019-06-30 | $3.14M 10-Q · filed 2020-10-29 | $6.02M 10-Q · filed 2019-08-01 | ||
| 2019-03-31 | $2.88M 10-Q · filed 2020-10-29 | |||
| 2018-12-31 | $10.39M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $2.67M 10-Q · filed 2019-10-30 | $5.26M derived: sum of 2 quarters · filed 2019-10-30 | $7.58M derived: sum of 3 quarters · filed 2019-10-30 | |
| 2018-06-30 | $2.59M 10-Q · filed 2019-10-30 | $4.91M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $2.31M 10-Q · filed 2019-10-30 | |||
| 2017-12-31 | $9.36M 10-K · filed 2020-02-21 | |||
| 2016-12-31 | $8.06M 10-K · filed 2019-02-27 | |||
| 2015-12-31 | $6.73M 10-K · filed 2018-03-08 | |||
| 2014-12-31 | $5.15M 10-K · filed 2017-03-08 | |||
| 2013-12-31 | $3.27M 10-K · filed 2016-03-09 | |||
| 2012-12-31 | $2.54M 10-K · filed 2015-03-16 | |||
| 2011-12-31 | $1.85M 10-K · filed 2014-03-07 | |||
| 2010-12-31 | $1.83M 10-K · filed 2013-03-12 | |||
| 2009-12-31 | $2.05M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |